0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Medical Patch Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-15H8253
Home | Market Reports | Health| Pharmacy
Global Transdermal Medical Patch Market Insights Forecast to 2028
BUY CHAPTERS

Global Transdermal Medical Patch Market Research Report 2023

Code: QYRE-Auto-15H8253
Report
November 2023
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transdermal Medical Patch Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Transdermal Medical Patch Market

Transdermal Medical Patch Market

Transdermal Medical Patch is a thin adhesive patch applied to the skin to deliver medication directly into the bloodstream through the skin's outer layers. This method allows controlled and continuous drug release over an extended period, avoiding the need for frequent dosing. Transdermal patches are used for various medical applications, including pain relief, hormone therapy, nicotine replacement, and motion sickness prevention.
According to new survey, global Transdermal Medical Patch market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Transdermal Medical Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Transdermal Medical Patch Market Report

Report Metric Details
Report Name Transdermal Medical Patch Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Methyl Salicylate-Based Patch
  • Rivastigmine Patch
  • Fentanyl Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Patch
  • Others
Segment by Application
  • Offline Channel
  • Online Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

Who are the main players in the Transdermal Medical Patch Market report?

Ans: The main players in the Transdermal Medical Patch Market are Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical

What are the Application segmentation covered in the Transdermal Medical Patch Market report?

Ans: The Applications covered in the Transdermal Medical Patch Market report are Offline Channel, Online Channel

What are the Type segmentation covered in the Transdermal Medical Patch Market report?

Ans: The Types covered in the Transdermal Medical Patch Market report are Methyl Salicylate-Based Patch, Rivastigmine Patch, Fentanyl Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Patch, Others

1 Transdermal Medical Patch Market Overview
1.1 Product Overview and Scope of Transdermal Medical Patch
1.2 Transdermal Medical Patch Segment by Type
1.2.1 Global Transdermal Medical Patch Market Value Comparison by Type (2023-2029)
1.2.2 Methyl Salicylate-Based Patch
1.2.3 Rivastigmine Patch
1.2.4 Fentanyl Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Patch
1.2.8 Others
1.3 Transdermal Medical Patch Segment by Application
1.3.1 Global Transdermal Medical Patch Market Value by Application: (2023-2029)
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Global Transdermal Medical Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Medical Patch Revenue 2018-2029
1.4.2 Global Transdermal Medical Patch Sales 2018-2029
1.4.3 Global Transdermal Medical Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Transdermal Medical Patch Market Competition by Manufacturers
2.1 Global Transdermal Medical Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Transdermal Medical Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Transdermal Medical Patch Average Price by Manufacturers (2018-2023)
2.4 Global Transdermal Medical Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Transdermal Medical Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Medical Patch, Product Type & Application
2.7 Transdermal Medical Patch Market Competitive Situation and Trends
2.7.1 Transdermal Medical Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Medical Patch Players Market Share by Revenue
2.7.3 Global Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Medical Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Medical Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Transdermal Medical Patch Global Transdermal Medical Patch Sales by Region: 2018-2029
3.2.1 Global Transdermal Medical Patch Sales by Region: 2018-2023
3.2.2 Global Transdermal Medical Patch Sales by Region: 2024-2029
3.3 Global Transdermal Medical Patch Global Transdermal Medical Patch Revenue by Region: 2018-2029
3.3.1 Global Transdermal Medical Patch Revenue by Region: 2018-2023
3.3.2 Global Transdermal Medical Patch Revenue by Region: 2024-2029
3.4 North America Transdermal Medical Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Medical Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Transdermal Medical Patch Sales by Country (2018-2029)
3.4.3 North America Transdermal Medical Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Medical Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Medical Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Transdermal Medical Patch Sales by Country (2018-2029)
3.5.3 Europe Transdermal Medical Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Medical Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Medical Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Transdermal Medical Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Transdermal Medical Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transdermal Medical Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Medical Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Transdermal Medical Patch Sales by Country (2018-2029)
3.7.3 Latin America Transdermal Medical Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Medical Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Medical Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Transdermal Medical Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Transdermal Medical Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Medical Patch Sales by Type (2018-2029)
4.1.1 Global Transdermal Medical Patch Sales by Type (2018-2023)
4.1.2 Global Transdermal Medical Patch Sales by Type (2024-2029)
4.1.3 Global Transdermal Medical Patch Sales Market Share by Type (2018-2029)
4.2 Global Transdermal Medical Patch Revenue by Type (2018-2029)
4.2.1 Global Transdermal Medical Patch Revenue by Type (2018-2023)
4.2.2 Global Transdermal Medical Patch Revenue by Type (2024-2029)
4.2.3 Global Transdermal Medical Patch Revenue Market Share by Type (2018-2029)
4.3 Global Transdermal Medical Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Transdermal Medical Patch Sales by Application (2018-2029)
5.1.1 Global Transdermal Medical Patch Sales by Application (2018-2023)
5.1.2 Global Transdermal Medical Patch Sales by Application (2024-2029)
5.1.3 Global Transdermal Medical Patch Sales Market Share by Application (2018-2029)
5.2 Global Transdermal Medical Patch Revenue by Application (2018-2029)
5.2.1 Global Transdermal Medical Patch Revenue by Application (2018-2023)
5.2.2 Global Transdermal Medical Patch Revenue by Application (2024-2029)
5.2.3 Global Transdermal Medical Patch Revenue Market Share by Application (2018-2029)
5.3 Global Transdermal Medical Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hisamitsu Pharmaceutical Transdermal Medical Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Transdermal Medical Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Transdermal Medical Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 UCB Pharma Transdermal Medical Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Transdermal Medical Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceutical Transdermal Medical Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.6.1 Nitto Denko Corporation Information
6.6.2 Nitto Denko Description and Business Overview
6.6.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nitto Denko Transdermal Medical Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grünenthal
6.8.1 Grünenthal Corporation Information
6.8.2 Grünenthal Description and Business Overview
6.8.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Grünenthal Transdermal Medical Patch Product Portfolio
6.8.5 Grünenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 IBSA Group Transdermal Medical Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GSK Transdermal Medical Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Transdermal Medical Patch Description and Business Overview
6.11.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Luye Pharma Group Transdermal Medical Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Transdermal Medical Patch Description and Business Overview
6.12.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Transdermal Medical Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Transdermal Medical Patch Description and Business Overview
6.13.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chattem Transdermal Medical Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Corporation Information
6.14.2 Dr Reddy’s Laboratories Transdermal Medical Patch Description and Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Dr Reddy’s Laboratories Transdermal Medical Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Transdermal Medical Patch Description and Business Overview
6.15.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Bayer Transdermal Medical Patch Product Portfolio
6.15.5 Bayer Recent Developments/Updates
6.16 Mundipharma
6.16.1 Mundipharma Corporation Information
6.16.2 Mundipharma Transdermal Medical Patch Description and Business Overview
6.16.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Mundipharma Transdermal Medical Patch Product Portfolio
6.16.5 Mundipharma Recent Developments/Updates
6.17 Endo International
6.17.1 Endo International Corporation Information
6.17.2 Endo International Transdermal Medical Patch Description and Business Overview
6.17.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Endo International Transdermal Medical Patch Product Portfolio
6.17.5 Endo International Recent Developments/Updates
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Corporation Information
6.18.2 Beijing Tide Pharmaceutical Transdermal Medical Patch Description and Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Beijing Tide Pharmaceutical Transdermal Medical Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Medical Patch Industry Chain Analysis
7.2 Transdermal Medical Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Medical Patch Production Mode & Process
7.4 Transdermal Medical Patch Sales and Marketing
7.4.1 Transdermal Medical Patch Sales Channels
7.4.2 Transdermal Medical Patch Distributors
7.5 Transdermal Medical Patch Customers
8 Transdermal Medical Patch Market Dynamics
8.1 Transdermal Medical Patch Industry Trends
8.2 Transdermal Medical Patch Market Drivers
8.3 Transdermal Medical Patch Market Challenges
8.4 Transdermal Medical Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Transdermal Medical Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Transdermal Medical Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Transdermal Medical Patch Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Transdermal Medical Patch Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Transdermal Medical Patch Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Transdermal Medical Patch Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Transdermal Medical Patch Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Transdermal Medical Patch Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Transdermal Medical Patch, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Transdermal Medical Patch, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Transdermal Medical Patch, Product Type & Application
    Table 12. Global Key Manufacturers of Transdermal Medical Patch, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Transdermal Medical Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Medical Patch as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Transdermal Medical Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Transdermal Medical Patch Sales by Region (2018-2023) & (K Units)
    Table 18. Global Transdermal Medical Patch Sales Market Share by Region (2018-2023)
    Table 19. Global Transdermal Medical Patch Sales by Region (2024-2029) & (K Units)
    Table 20. Global Transdermal Medical Patch Sales Market Share by Region (2024-2029)
    Table 21. Global Transdermal Medical Patch Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Transdermal Medical Patch Revenue Market Share by Region (2018-2023)
    Table 23. Global Transdermal Medical Patch Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Transdermal Medical Patch Revenue Market Share by Region (2024-2029)
    Table 25. North America Transdermal Medical Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Transdermal Medical Patch Sales by Country (2018-2023) & (K Units)
    Table 27. North America Transdermal Medical Patch Sales by Country (2024-2029) & (K Units)
    Table 28. North America Transdermal Medical Patch Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Transdermal Medical Patch Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Transdermal Medical Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Transdermal Medical Patch Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Transdermal Medical Patch Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Transdermal Medical Patch Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Transdermal Medical Patch Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Transdermal Medical Patch Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Transdermal Medical Patch Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Transdermal Medical Patch Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Transdermal Medical Patch Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Transdermal Medical Patch Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Transdermal Medical Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Transdermal Medical Patch Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Transdermal Medical Patch Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Transdermal Medical Patch Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Transdermal Medical Patch Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Transdermal Medical Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Transdermal Medical Patch Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Transdermal Medical Patch Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Transdermal Medical Patch Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Transdermal Medical Patch Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Transdermal Medical Patch Sales (K Units) by Type (2018-2023)
    Table 51. Global Transdermal Medical Patch Sales (K Units) by Type (2024-2029)
    Table 52. Global Transdermal Medical Patch Sales Market Share by Type (2018-2023)
    Table 53. Global Transdermal Medical Patch Sales Market Share by Type (2024-2029)
    Table 54. Global Transdermal Medical Patch Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Transdermal Medical Patch Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Transdermal Medical Patch Revenue Market Share by Type (2018-2023)
    Table 57. Global Transdermal Medical Patch Revenue Market Share by Type (2024-2029)
    Table 58. Global Transdermal Medical Patch Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Transdermal Medical Patch Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Transdermal Medical Patch Sales (K Units) by Application (2018-2023)
    Table 61. Global Transdermal Medical Patch Sales (K Units) by Application (2024-2029)
    Table 62. Global Transdermal Medical Patch Sales Market Share by Application (2018-2023)
    Table 63. Global Transdermal Medical Patch Sales Market Share by Application (2024-2029)
    Table 64. Global Transdermal Medical Patch Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Transdermal Medical Patch Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Transdermal Medical Patch Revenue Market Share by Application (2018-2023)
    Table 67. Global Transdermal Medical Patch Revenue Market Share by Application (2024-2029)
    Table 68. Global Transdermal Medical Patch Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Transdermal Medical Patch Price (US$/Unit) by Application (2024-2029)
    Table 70. Hisamitsu Pharmaceutical Corporation Information
    Table 71. Hisamitsu Pharmaceutical Description and Business Overview
    Table 72. Hisamitsu Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Hisamitsu Pharmaceutical Transdermal Medical Patch Product
    Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
    Table 75. Johnson & Johnson Corporation Information
    Table 76. Johnson & Johnson Description and Business Overview
    Table 77. Johnson & Johnson Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Johnson & Johnson Transdermal Medical Patch Product
    Table 79. Johnson & Johnson Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Novartis Transdermal Medical Patch Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. UCB Pharma Corporation Information
    Table 86. UCB Pharma Description and Business Overview
    Table 87. UCB Pharma Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. UCB Pharma Transdermal Medical Patch Product
    Table 89. UCB Pharma Recent Developments/Updates
    Table 90. Mylan Corporation Information
    Table 91. Mylan Description and Business Overview
    Table 92. Mylan Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Mylan Transdermal Medical Patch Product
    Table 94. Mylan Recent Developments/Updates
    Table 95. Teva Pharmaceutical Corporation Information
    Table 96. Teva Pharmaceutical Description and Business Overview
    Table 97. Teva Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Teva Pharmaceutical Transdermal Medical Patch Product
    Table 99. Teva Pharmaceutical Recent Developments/Updates
    Table 100. Nitto Denko Corporation Information
    Table 101. Nitto Denko Description and Business Overview
    Table 102. Nitto Denko Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Nitto Denko Transdermal Medical Patch Product
    Table 104. Nitto Denko Recent Developments/Updates
    Table 105. Grünenthal Corporation Information
    Table 106. Grünenthal Description and Business Overview
    Table 107. Grünenthal Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Grünenthal Transdermal Medical Patch Product
    Table 109. Grünenthal Recent Developments/Updates
    Table 110. IBSA Group Corporation Information
    Table 111. IBSA Group Description and Business Overview
    Table 112. IBSA Group Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. IBSA Group Transdermal Medical Patch Product
    Table 114. IBSA Group Recent Developments/Updates
    Table 115. GSK Corporation Information
    Table 116. GSK Description and Business Overview
    Table 117. GSK Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. GSK Transdermal Medical Patch Product
    Table 119. GSK Recent Developments/Updates
    Table 120. Luye Pharma Group Corporation Information
    Table 121. Luye Pharma Group Description and Business Overview
    Table 122. Luye Pharma Group Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. Luye Pharma Group Transdermal Medical Patch Product
    Table 124. Luye Pharma Group Recent Developments/Updates
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Business Overview
    Table 127. Pfizer Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Pfizer Transdermal Medical Patch Product
    Table 129. Pfizer Recent Developments/Updates
    Table 130. Chattem Corporation Information
    Table 131. Chattem Description and Business Overview
    Table 132. Chattem Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 133. Chattem Transdermal Medical Patch Product
    Table 134. Chattem Recent Developments/Updates
    Table 135. Dr Reddy’s Laboratories Corporation Information
    Table 136. Dr Reddy’s Laboratories Description and Business Overview
    Table 137. Dr Reddy’s Laboratories Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 138. Dr Reddy’s Laboratories Transdermal Medical Patch Product
    Table 139. Dr Reddy’s Laboratories Recent Developments/Updates
    Table 140. Bayer Corporation Information
    Table 141. Bayer Description and Business Overview
    Table 142. Bayer Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 143. Bayer Transdermal Medical Patch Product
    Table 144. Bayer Recent Developments/Updates
    Table 145. Mundipharma Corporation Information
    Table 146. Mundipharma Description and Business Overview
    Table 147. Mundipharma Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 148. Mundipharma Transdermal Medical Patch Product
    Table 149. Mundipharma Recent Developments/Updates
    Table 150. Endo International Corporation Information
    Table 151. Endo International Description and Business Overview
    Table 152. Endo International Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 153. Endo International Transdermal Medical Patch Product
    Table 154. Endo International Recent Developments/Updates
    Table 155. Beijing Tide Pharmaceutical Corporation Information
    Table 156. Beijing Tide Pharmaceutical Description and Business Overview
    Table 157. Beijing Tide Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 158. Beijing Tide Pharmaceutical Transdermal Medical Patch Product
    Table 159. Beijing Tide Pharmaceutical Recent Developments/Updates
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Transdermal Medical Patch Distributors List
    Table 163. Transdermal Medical Patch Customers List
    Table 164. Transdermal Medical Patch Market Trends
    Table 165. Transdermal Medical Patch Market Drivers
    Table 166. Transdermal Medical Patch Market Challenges
    Table 167. Transdermal Medical Patch Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Transdermal Medical Patch
    Figure 2. Global Transdermal Medical Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Transdermal Medical Patch Market Share by Type in 2022 & 2029
    Figure 4. Methyl Salicylate-Based Patch Product Picture
    Figure 5. Rivastigmine Patch Product Picture
    Figure 6. Fentanyl Patch Product Picture
    Figure 7. Lidocaine Patch Product Picture
    Figure 8. Diclofenac Patch Product Picture
    Figure 9. Nicotine Patch Product Picture
    Figure 10. Others Product Picture
    Figure 11. Global Transdermal Medical Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 12. Global Transdermal Medical Patch Market Share by Application in 2022 & 2029
    Figure 13. Offline Channel
    Figure 14. Online Channel
    Figure 15. Global Transdermal Medical Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Transdermal Medical Patch Market Size (2018-2029) & (US$ Million)
    Figure 17. Global Transdermal Medical Patch Sales (2018-2029) & (K Units)
    Figure 18. Global Transdermal Medical Patch Average Price (US$/Unit) & (2018-2029)
    Figure 19. Transdermal Medical Patch Report Years Considered
    Figure 20. Transdermal Medical Patch Sales Share by Manufacturers in 2022
    Figure 21. Global Transdermal Medical Patch Revenue Share by Manufacturers in 2022
    Figure 22. The Global 5 and 10 Largest Transdermal Medical Patch Players: Market Share by Revenue in 2022
    Figure 23. Transdermal Medical Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 24. Global Transdermal Medical Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 25. North America Transdermal Medical Patch Sales Market Share by Country (2018-2029)
    Figure 26. North America Transdermal Medical Patch Revenue Market Share by Country (2018-2029)
    Figure 27. United States Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Canada Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. Europe Transdermal Medical Patch Sales Market Share by Country (2018-2029)
    Figure 30. Europe Transdermal Medical Patch Revenue Market Share by Country (2018-2029)
    Figure 31. Germany Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. France Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. U.K. Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Italy Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Russia Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Asia Pacific Transdermal Medical Patch Sales Market Share by Region (2018-2029)
    Figure 37. Asia Pacific Transdermal Medical Patch Revenue Market Share by Region (2018-2029)
    Figure 38. China Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Japan Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. South Korea Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. India Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Australia Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. China Taiwan Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Transdermal Medical Patch Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Transdermal Medical Patch Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Transdermal Medical Patch Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Transdermal Medical Patch Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. UAE Transdermal Medical Patch Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Transdermal Medical Patch by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Transdermal Medical Patch by Type (2018-2029)
    Figure 57. Global Transdermal Medical Patch Price (US$/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Transdermal Medical Patch by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Transdermal Medical Patch by Application (2018-2029)
    Figure 60. Global Transdermal Medical Patch Price (US$/Unit) by Application (2018-2029)
    Figure 61. Transdermal Medical Patch Value Chain
    Figure 62. Transdermal Medical Patch Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36H8345
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34R905
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2R9930
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34L14446
Mon Apr 15 00:00:00 UTC 2024

Add to Cart